CareDx, Inc.
- Stock
- Ticker CDNA
- ISIN US14167L1035
- Nasdaq
Performance, volatility and drawdowns of CareDx, Inc. since 11/2016, with distributions reinvested and calculated in US dollars. As of 20 Nov 2026.
Performance
$10,000 grew to $233,333. Global equities (VT): $29,042.
Distributions reinvested, before taxes and brokerage costs. Dashed: Global equities (VT) for comparison.
Declines from the peak
Lowest point −94.9% in 10/2023, measured from the peak in 01/2021. The old peak has not been reached again yet.
Financial statements
Amounts in $ millions from filings with the SEC, earnings per share in $; fourth quarter and quarterly cash flow derived from year-to-date figures
| Quarter end | 12/2024 | 03/2025 | 06/2025 | 09/2025 | 12/2025 | 03/2026 | 06/2026 | 09/2026 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | 87 | 85 | 87 | 100 | 108 | 118 | 132 | 139 |
| Operating income | 84 | -13 | -11 | -0.2 | -6.0 | 1.2 | 113 | 8.1 |
| EBITDA | 88 | -9.8 | -7.4 | 3.6 | -2.2 | 5.1 | 116 | 15 |
| Net income | 88 | -10 | -8.6 | 1.7 | -4.1 | 2.8 | 111 | 19 |
| Earnings per share | 1.60 | -0.19 | -0.16 | 0.03 | -0.08 | 0.05 | 2.07 | 0.35 |
| Balance sheet | ||||||||
| Total assets | 491 | 490 | 444 | 432 | 413 | 411 | 533 | 641 |
| Liabilities | 113 | 110 | 117 | 121 | 110 | 98 | 107 | 174 |
| Equity | 378 | 379 | 327 | 311 | 303 | 314 | 426 | 467 |
| Cash | 115 | 89 | 68 | 91 | 65 | 78 | 374 | 250 |
| Cash flow | ||||||||
| Operating cash flow | 22 | -27 | 9.9 | 37 | 21 | 4.3 | 31 | 13 |
| Capital expenditure | – | -1.6 | -1.0 | -1.3 | – | -3.8 | -1.9 | -1.6 |
| Free cash flow | 22 | -28 | 8.9 | 36 | 21 | 0.5 | 29 | 11 |
Value it:DCF calculatorMultiples calculator
Annual returns
Best year 2018 at +242.5%, weakest 2022 at −74.9%. 5 of 9 full years were positive. * partial year.
Quarterly reports
Filing date with the SEC and earnings per share of the quarter
| Day | Earnings per share |
|---|---|
| 29 Oct 2026 | $0.35 |
| 30 Jul 2026 | $2.07 |
| 28 Apr 2026 | $0.05 |
| 25 Feb 2026 | −$0.08 |
| 4 Nov 2025 | $0.03 |
| 6 Aug 2025 | −$0.16 |
| 30 Apr 2025 | −$0.19 |
| 28 Feb 2025 | $1.60 |
| 4 Nov 2024 | −$0.20 |
| 31 Jul 2024 | −$0.09 |
| 9 May 2024 | −$0.38 |
| 28 Feb 2024 | −$2.20 |
Key metrics
Metrics of 15 Nov 2026; P/E, P/B, P/S, market cap and dividend yield at the last close.
Valuation
- Market cap
- €3.3bn
- Market cap in trading currency
- $3.68bn
- Enterprise value
- $3.43bn
- P/E
- 29.3
- P/S
- 7.39
- P/B
- 7.87
- EV/Sales
- 6.89
- EV/EBITDA
- 25.5
- Earnings yield
- 3.4%
- FCF yield
- 1.9%
Results (last four quarters)
- Revenue
- $497m
- Gross profit
- –
- EBITDA
- $134m
- Net income
- $129m
- Earnings per share
- $2.39
- Revenue per share
- $9.47
- Revenue growth
- +39.3%
- Earnings growth
- +1,051.8%
Profitability
- Gross margin
- –
- Operating margin
- 23.4%
- Net margin
- 25.9%
- Return on equity
- 33.0%
- Return on assets
- 20.1%
Balance sheet and cash flow
- Cash
- $250m
- Cash per share
- $4.77
- Financial debt
- –
- Debt/equity %
- –
- Current ratio
- 2.31
- Book value per share
- $8.90
- Operating cash flow
- $69.0m
- Free cash flow
- $69.0m
Dividend
- Dividend yield
- 0.00%
- Dividend (12 months)
- $0.00
- Yield (12 months)
- 0.00%
- Payout ratio
- 0%
- Ex-dividend date
- –
Shares and trading
- Shares outstanding
- 52.5m
- Volume
- 780,998
- Avg. volume 3 months
- 1.33m
- Relative volume
- 0.6
Price and technicals
- Price
- $70.00
- 1 day
- −2.7%
- 52-week high
- $88.47
- 52-week low
- $15.76
- Distance to 52-week high
- −20.9%
- Distance to 52-week low
- +344.2%
- Distance to 50-day line
- +2.0%
- Distance to 200-day line
- +84.0%
- RSI (14)
- 44
- Volatility 1M
- 94.7%
Performance
- 1 week
- −10.1%
- 1 month
- +1.2%
- 3 months
- +47.4%
- 6 months
- +223.6%
- YTD
- +271.5%
- 1 year
- +338.0%
Dates
- Fiscal year end
- 31 Dec 2025
- Most recent quarter
- 30 Sep 2026
Frequently asked questions
How has CDNA performed since 11/2016?
$10,000 grew to $233,333 by 20 Nov 2026, which is +37.0% per year. Distributions are reinvested; taxes and brokerage costs are not deducted.
How volatile is CDNA?
Volatility was 86.8% per year, measured on monthly returns. The largest decline from a peak was −94.9%, with the low in 10/2023.
How does CDNA compare with a broad equity ETF?
Over the same period Global equities (VT) returned +11.3% per year at 15.1% volatility, CDNA returned +37.0% at 86.8%. The correlation of monthly returns was 0.28; 1 would mean they moved in lockstep.
Which currency are the figures in?
In US dollars, the currency of the US listing.